<DOC>
	<DOCNO>NCT02529150</DOCNO>
	<brief_summary>One four death United States due cancer , one three woman develop cancer lifetime . Despite improvement survival among form cancer , ovarian cancer prognosis remain poor . Eighty percent woman ovarian cancer present advance disease ( stage 3 4 ) 5-year survival range 18-34 % .2 Among patient stage III IV epithelial ovarian cancer ( EOC ) , recurrence rate high.4 Therefore , intervention focus prevent recurrence slow progression EOC critical problem field . The investigator submit R21 NCI dose response exercise intervention trial examine dose response effect aerobic exercise biomarkers relevant ovarian cancer progression recurrence . The reviewer would like assurance investigator recruit ovarian cancer patient exercise study woman exercise protocol plan prescribe high dose exercise .</brief_summary>
	<brief_title>WISER After Ovarian Cancer - Exercise Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>Diagnosis stage IIIIV EOC , complete surgery , &gt; 12 month life expectancy ( physician estimate ) , able walk 15 minute time ( use cane acceptable ) . medical psychiatric condition ( beyond ovarian cancer , treatment , symptom ) would impair ability test study hypothesis ( e.g . cardiac , pulmonary , orthopedic history would prohibit program walking exercise ; psychotic disorder , dementia , inability give inform consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>